ENTRY       C00355                      Compound
NAME        3,4-Dihydroxy-L-phenylalanine;
            L-Dopa;
            3-Hydroxy-L-tyrosine;
            L-beta-(3,4-Dihydroxyphenyl)alanine;
            Levodopa;
            Dihydroxy-L-phenylalanine
FORMULA     C9H11NO4
EXACT_MASS  197.0688
MOL_WEIGHT  197.1879
REMARK      Same as: D00059
REACTION    R00031 R00045 R00731 R01815 R02075 R02076 R02077 R02078 
            R02080 R03672 R07212 R08443 R08827 R08836 R08846 R08920 
            R11916 R12541 R12611 R13031 R13032
PATHWAY     map00350  Tyrosine metabolism
            map00950  Isoquinoline alkaloid biosynthesis
            map00965  Betalain biosynthesis
            map01060  Biosynthesis of plant secondary metabolites
            map01063  Biosynthesis of alkaloids derived from shikimate pathway
            map01100  Metabolic pathways
            map01110  Biosynthesis of secondary metabolites
            map04728  Dopaminergic synapse
            map04917  Prolactin signaling pathway
            map05012  Parkinson disease
            map05030  Cocaine addiction
            map05031  Amphetamine addiction
            map05034  Alcoholism
MODULE      M00042  Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline
            M00961  Betacyanin biosynthesis, L-tyrosine => amaranthin
NETWORK     nt06028  Dopamine and serotonin metabolism
            nt06463  Parkinson disease
ENZYME      1.10.3.1        1.11.2.6        1.13.11.29      1.13.11.30      
            1.13.11.-       1.13.12.15      1.14.16.2       1.14.18.1       
            1.14.-.-        2.6.1.49        4.1.1.25        4.1.1.28        
            4.1.1.107       4.3.1.22
BRITE       Compounds with biological roles [BR:br08001]
             Peptides
              Amino acids
               Other amino acids
                C00355  3,4-Dihydroxy-L-phenylalanine
             Hormones and transmitters
              Neurotransmitters
               Amino acids
                C00355  Dopa
            Prodrugs [br08324.html]
             C00355
            Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00059)]
             N NERVOUS SYSTEM
              N04 ANTI-PARKINSON DRUGS
               N04B DOPAMINERGIC AGENTS
                N04BA Dopa and dopa derivatives
                 N04BA01 Levodopa
                  D00059  Levodopa (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302(D00059)]
             Antiparkinson Agents
              Dopamine Precursors and/or L-Amino Acid Decarboxylase Inhibitors
               Levodopa
                D00059  Levodopa (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301(D00059)]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               116  Antiparkinsonian agents
                1164  Levodopas
                 D00059  Levodopa (JP18/USP/INN)
            Drug groups [BR:br08330(D00059)]
             Neuropsychiatric agent
              DG01472  Dopamine agonist
               D00059  Levodopa
              DG01967  Antiparkinson agent
               D00059  Levodopa
            Drug classes [BR:br08332(D00059)]
             Neuropsychiatric agent
              DG01967  Antiparkinson agent
               D00059  Levodopa
            Target-based classification of drugs [BR:br08310(D00059)]
             G Protein-coupled receptors
              Rhodopsin family
               Dopamine
                DRD
                 D00059  Levodopa (JP18/USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00059)]
             Chemicals
              D00059  Levodopa
            New drug approvals in Europe [br08329.html(D00059)]
             European public assessment reports (EPAR) authorised medicine
              D00059
            Prodrugs [br08324.html(D00059)]
             D00059
DBLINKS     CAS: 59-92-7
            PubChem: 3648
            ChEBI: 15765
            KNApSAcK: C00001357
            PDB-CCD: DAH
            3DMET: B01224
            NIKKAJI: J9.225H
ATOM        14
            1   C8y C    22.9600  -19.2500
            2   C8y C    22.9600  -20.6500
            3   C8x C    24.1500  -18.5500
            4   O1a O    21.7000  -18.5500
            5   C8x C    24.1500  -21.3500
            6   O1a O    21.7000  -21.3500
            7   C8y C    25.3400  -19.2500
            8   C8x C    25.3400  -20.6500
            9   C1b C    26.6000  -18.6200
            10  C1c C    27.7900  -19.2500
            11  C6a C    28.9800  -18.6200
            12  N1a N    27.7900  -20.6500
            13  O6a O    30.2400  -19.2500
            14  O6a O    28.9800  -17.2200
BOND        14
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 2
            5     2   6 1
            6     3   7 1
            7     5   8 1
            8     7   9 1
            9     9  10 1
            10   10  11 1
            11   10  12 1 #Up
            12   11  13 1
            13   11  14 2
            14    7   8 2
///
